Joseph A. Miccio, MD (@jamradonc) 's Twitter Profile
Joseph A. Miccio, MD

@jamradonc

Father, husband, and radiation oncologist | Assistant Professor @PennStateHershey | former resident @yaleradonc | Pitt Panther fan (H2P)

ID: 1043903612303396864

calendar_today23-09-2018 16:43:10

207 Tweet

715 Followers

694 Following

JAMA Oncology (@jamaonc) 's Twitter Profile Photo

Since the 21st Century Cures Act took effect, almost 80% of test results are viewed by patients with cancer before the ordering clinician, a doubling over the prior five years. ja.ma/3O7ZnU0

Joseph A. Miccio, MD (@jamradonc) 's Twitter Profile Photo

Check out our work culminating in a web tool to predict the risk of brain metastasis in patients newly diagnosed with cancer! Paper: pubmed.ncbi.nlm.nih.gov/38388667/ Webtool: tinyurl.com/brain-mets Thanks to all of our collaborators especially Nicholas Zaorsky, MD MS and Ming Wang_CWRU!!

James Yu (@jamesbyu) 's Twitter Profile Photo

Updated Analysis of Comparative Toxicity of Proton and Photon Radiation for Prostate Cancer | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC… 11 years ago we published our findings of no difference. Given more time and more progress, we looked again… Cary Gross Yale COPPER Center

Jeff Yang MD FACS (@chifujeffyang) 's Twitter Profile Photo

.Alexandra Potter led a study in Journal of Clinical Oncology showing that using smoking duration, instead of pack-years, to determine #lungcancerscreening eligibility is more equitable and greatly increases opportunities for early lung cancer detection. ascopubs.org/doi/10.1200/JC…

.<a href="/alexandra_p_24/">Alexandra Potter</a> led a study in <a href="/JCO_ASCO/">Journal of Clinical Oncology</a> showing that using smoking duration, instead of pack-years, to determine #lungcancerscreening eligibility is more equitable and greatly increases opportunities for early lung cancer detection.
ascopubs.org/doi/10.1200/JC…
Rami Manochakian MD, FASCO Cancer Education (@rmanochakian) 's Twitter Profile Photo

🔥🚨OncoAlert Hot Off the Press BIG NEWS Press Release by AstraZeneca #ADRIATIC phase 3 trial of #Durvalumab vs #Placebo after concurrent chemoradiotherapy in pts with limited-stage #SmallCell #LungCancer met dual primary endpoints of ⬆️#OS & ⬆️#PFS 👇🏼 astrazeneca.com/media-centre/p…

🔥🚨<a href="/OncoAlert/">OncoAlert</a> Hot Off the Press
BIG NEWS Press Release by <a href="/AstraZeneca/">AstraZeneca</a> 

#ADRIATIC phase 3 trial of #Durvalumab vs #Placebo after concurrent chemoradiotherapy
in pts with limited-stage #SmallCell #LungCancer met dual primary endpoints of ⬆️#OS &amp; ⬆️#PFS
👇🏼
astrazeneca.com/media-centre/p…
Henry S. Park, MD, MPH (@henryparkmd) 's Twitter Profile Photo

ARS Appropriateness Use Criteria for Unresectable Locally Advanced Non–Small Cell Lung Cancer Strong push for IMRT; discussion of nuances for PD-L1 negative / EGFR mutant / poor performance status or pulmonary function Kudos to George Rodrigues and Kristin Higgins! jamanetwork.com/journals/jamao…

Joe Y Chang (@joechangmd) 's Twitter Profile Photo

Limited stage small cell lung carcinoma treated with concurrent chemo-radiotherapy, adjuvant Durva IO improved OS and PFS, a new standard of care.

Limited stage small cell lung carcinoma treated with concurrent chemo-radiotherapy, adjuvant Durva IO improved OS and PFS, a new standard of care.
Rahul Tendulkar, MD (@rtendulkarmd) 's Twitter Profile Photo

Burnout & moral injury in medicine have affected so many health care workers. As a mid-career physician, here’s what I’ve learned to combat it - I hope others find it to be helpful. In Search of Joy and Meaning in Modern Medicine JCO Oncology Practice ascopubs.org/doi/pdf/10.120…

Burnout &amp; moral injury in medicine have affected so many health care workers. As a mid-career physician, here’s what I’ve learned to combat it - I hope others find it to be helpful.
In Search of Joy and Meaning in Modern Medicine <a href="/JCOOP_ASCO/">JCO Oncology Practice</a> ascopubs.org/doi/pdf/10.120…
Rahul Tendulkar, MD (@rtendulkarmd) 's Twitter Profile Photo

Preparing to give a lecture on physician wellness & professional fulfillment to med students @CleClinicLCM - here are some useful references 1/

Rami Manochakian MD, FASCO Cancer Education (@rmanochakian) 's Twitter Profile Photo

🚨🔥 1/2 OncoAlert Hot off the press. Just published NEJM in conjunction with presentation on updated data ESMO - Eur. Oncology #ESMO2024 Results of #ADRIATIC trial of #Durvalumab vs #Placebo after #Chemoradiotherapy in Limited-Stage #SmallCell #LungCancer. 👇🏼 nejm.org/doi/full/10.10…

🚨🔥 1/2 <a href="/OncoAlert/">OncoAlert</a> Hot off the press.

Just published <a href="/NEJM/">NEJM</a> in conjunction with presentation on updated data <a href="/myESMO/">ESMO - Eur. Oncology</a> #ESMO2024 

Results of #ADRIATIC trial of #Durvalumab vs #Placebo after #Chemoradiotherapy in Limited-Stage #SmallCell #LungCancer.

👇🏼
nejm.org/doi/full/10.10…
Henry S. Park, MD, MPH (@henryparkmd) 's Twitter Profile Photo

Just finished learning the AJCC 8th edition? Get ready for the 9th edition in less than 3 months! Kudos for Frank Detterbeck and team for this CHEST summary of staging updates in lung cancer. IASLC Yale Cancer Center Yale Thoracic SurgeryYale Radiation Oncology Residency⁩ sciencedirect.com/science/articl…

OncoAlert (@oncoalert) 's Twitter Profile Photo

Palliative radiotherapy versus best supportive care in patients with painful hepatic cancer (CCTG HE1) out on The Lancet Oncology thelancet.com/journals/lanon… This phase 3 trial investigated whether radiotherapy ☢️improves hepatic pain in patients with hepatocellular carcinoma or liver

Palliative radiotherapy versus best supportive care in patients with painful hepatic cancer (CCTG HE1) out on <a href="/TheLancetOncol/">The Lancet Oncology</a> 

thelancet.com/journals/lanon…

This phase 3 trial investigated whether radiotherapy ☢️improves hepatic pain in patients with hepatocellular carcinoma or liver
Dr. Nina Niu Sanford (@niusanford) 's Twitter Profile Photo

Excited to share about NRG GI-011 (aka LAP100) – anticipated opening in mid/early 2025. In this Phase III RCT, we are assessing the benefit of dose-escalated radiotherapy in patients with locally advanced unresectable pancreas cancer. 🧵1/11

Excited to share about NRG GI-011 (aka LAP100) – anticipated opening in mid/early 2025.

In this Phase III RCT, we are assessing the benefit of dose-escalated radiotherapy in patients with locally advanced unresectable pancreas cancer. 🧵1/11
Jeff Ryckman (@jryckman3) 's Twitter Profile Photo

🧵1/ 🚨New case report out in Cureus: Face the Pain: Radiobiological and Clinical Considerations of Re-radiosurgery to the Trigeminal Nerve 👉 A deep dive into a unique case of medically refractory TGN in the setting of a petroclival meningioma. 🔗 doi.org/10.7759/cureus…

🧵1/ 

🚨New case report out in Cureus:

Face the Pain: Radiobiological and Clinical Considerations of Re-radiosurgery to the Trigeminal Nerve

👉 A deep dive into a unique case of medically refractory TGN in the setting of a petroclival meningioma.

🔗 doi.org/10.7759/cureus…